Literature DB >> 25404064

Basic mechanisms of epileptogenesis in pediatric cortical dysplasia.

Sara Abdijadid1, Gary W Mathern, Michael S Levine, Carlos Cepeda.   

Abstract

Cortical dysplasia (CD) is a neurodevelopmental disorder due to aberrant cell proliferation and differentiation. Advances in neuroimaging have proven effective in early identification of the more severe lesions and timely surgical removal to treat epilepsy. However, the exact mechanisms of epileptogenesis are not well understood. This review examines possible mechanisms based on anatomical and electrophysiological studies. CD can be classified as CD type I consisting of architectural abnormalities, CD type II with the presence of dysmorphic cytomegalic neurons and balloon cells, and CD type III which occurs in association with other pathologies. Use of freshly resected brain tissue has allowed a better understanding of basic mechanisms of epileptogenesis and has delineated the role of abnormal cells and synaptic activity. In CD type II, it was demonstrated that balloon cells do not initiate epileptic activity, whereas dysmorphic cytomegalic and immature neurons play an important role in generation and propagation of epileptic discharges. An unexpected finding in pediatric CD was that GABA synaptic activity is not reduced, and in fact, it may facilitate the occurrence of epileptic activity. This could be because neuronal circuits display morphological and functional signs of dysmaturity. In consequence, drugs that increase GABA function may prove ineffective in pediatric CD. In contrast, drugs that counteract depolarizing actions of GABA or drugs that inhibit the mammalian target of rapamycin (mTOR) pathway could be more effective.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Balloon cells; Cortical dysplasia; Dysmorphic neurons; Epileptogenesis; mTOR pathway

Mesh:

Substances:

Year:  2014        PMID: 25404064      PMCID: PMC4442638          DOI: 10.1111/cns.12345

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  147 in total

1.  Epileptiform discharges in the human dysplastic neocortex: in vitro physiology and pharmacology.

Authors:  M Avoli; A Bernasconi; D Mattia; A Olivier; G G Hwa
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

2.  Cajal-Retzius cell density as marker of type of focal cortical dysplasia.

Authors:  R Garbelli; C Frassoni; A Ferrario; L Tassi; M Bramerio; R Spreafico
Journal:  Neuroreport       Date:  2001-08-28       Impact factor: 1.837

Review 3.  Developing networks play a similar melody.

Authors:  Y Ben-Ari
Journal:  Trends Neurosci       Date:  2001-06       Impact factor: 13.837

4.  Neurons recorded from pediatric epilepsy surgery patients with cortical dysplasia.

Authors:  G W Mathern; C Cepeda; R S Hurst; J Flores-Hernandez; D Mendoza; M S Levine
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

Review 5.  A possible role for gap junctions in generation of very fast EEG oscillations preceding the onset of, and perhaps initiating, seizures.

Authors:  R D Traub; M A Whittington; E H Buhl; F E LeBeau; A Bibbig; S Boyd; H Cross; T Baldeweg
Journal:  Epilepsia       Date:  2001-02       Impact factor: 5.864

6.  NMDA-receptors 1 and 2A/B coassembly increased in human epileptic focal cortical dysplasia.

Authors:  N Mikuni; T L Babb; Z Ying; I Najm; K Nishiyama; C Wylie; K Yacubova; T Okamoto; W Bingaman
Journal:  Epilepsia       Date:  1999-12       Impact factor: 5.864

7.  Stereoelectroencephalography in focal cortical dysplasia: a 3D approach to delineating the dysplastic cortex.

Authors:  F Chassoux; B Devaux; E Landré; B Turak; F Nataf; P Varlet; J P Chodkiewicz; C Daumas-Duport
Journal:  Brain       Date:  2000-08       Impact factor: 13.501

8.  Focal cortical dysplasia in children.

Authors:  A Hilbig; T L Babb; I Najm; Z Ying; E Wyllie; W Bingaman
Journal:  Dev Neurosci       Date:  1999-11       Impact factor: 2.984

9.  Epileptogenicity correlated with increased N-methyl-D-aspartate receptor subunit NR2A/B in human focal cortical dysplasia.

Authors:  I M Najm; Z Ying; T Babb; A Mohamed; J Hadam; E LaPresto; E Wyllie; P Kotagal; W Bingaman; N Foldvary; H Morris; H O Lüders
Journal:  Epilepsia       Date:  2000-08       Impact factor: 5.864

10.  Cortical dysplasia: electroclinical, imaging, and neuropathologic study of 13 patients.

Authors:  L Tassi; B Pasquier; L Minotti; R Garbelli; P Kahane; A L Benabid; G Battaglia; C Munari; R Spreafico
Journal:  Epilepsia       Date:  2001-09       Impact factor: 5.864

View more
  20 in total

1.  RHEB/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity.

Authors:  Martina Proietti Onori; Linda M C Koene; Carmen B Schäfer; Mark Nellist; Marcel de Brito van Velze; Zhenyu Gao; Ype Elgersma; Geeske M van Woerden
Journal:  PLoS Biol       Date:  2021-05-26       Impact factor: 8.029

2.  Down-Regulated Expression of Liver X Receptor beta in Cortical Lesions of Patients with Focal Cortical Dysplasia.

Authors:  Xin Chen; Lukang Wang; Bing Chen; Jiong Yue; Gang Zhu; Chunqing Zhang; Shiyong Liu; Hui Yang
Journal:  J Mol Neurosci       Date:  2016-07-20       Impact factor: 3.444

Review 3.  Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations.

Authors:  Carlos Cepeda; Katerina D Oikonomou; Damian Cummings; Joshua Barry; Vannah-Wila Yazon; Dickson T Chen; Janelle Asai; Christopher K Williams; Harry V Vinters
Journal:  J Neurosci Res       Date:  2019-07-28       Impact factor: 4.164

4.  Multimodal MRI profiling of focal cortical dysplasia type II.

Authors:  Seok-Jun Hong; Boris C Bernhardt; Benoit Caldairou; Jeffery A Hall; Marie C Guiot; Dewi Schrader; Neda Bernasconi; Andrea Bernasconi
Journal:  Neurology       Date:  2017-01-27       Impact factor: 9.910

5.  Cytochrome c oxidase deficit is associated with the seizure onset zone in young patients with focal cortical dysplasia Type II.

Authors:  Lili Miles; Hansel M Greiner; Francesco T Mangano; Paul S Horn; James L Leach; Michael V Miles
Journal:  Metab Brain Dis       Date:  2015-05-10       Impact factor: 3.584

6.  Long-term outcomes of epilepsy surgery in tuberous sclerosis complex.

Authors:  Shuli Liang; Juncheng Zhang; Zhixian Yang; Shaohui Zhang; Zhiqiang Cui; Jianfei Cui; Jiwu Zhang; Na Liu; Ping Ding
Journal:  J Neurol       Date:  2017-05-17       Impact factor: 4.849

7.  Hyperactive mTOR signals in the proopiomelanocortin-expressing hippocampal neurons cause age-dependent epilepsy and premature death in mice.

Authors:  Yuki Matsushita; Yasunari Sakai; Mitsunori Shimmura; Hiroshi Shigeto; Miki Nishio; Satoshi Akamine; Masafumi Sanefuji; Yoshito Ishizaki; Hiroyuki Torisu; Yusaku Nakabeppu; Akira Suzuki; Hidetoshi Takada; Toshiro Hara
Journal:  Sci Rep       Date:  2016-03-10       Impact factor: 4.379

8.  Genome-wide DNA Methylation and RNAseq Analyses Identify Aberrant Signalling Pathways in Focal Cortical Dysplasia (FCD) Type II.

Authors:  Aparna Banerjee Dixit; Devina Sharma; Manjari Tripathi; Arpna Srivastava; Debasmita Paul; Deepak Prakash; Chitra Sarkar; Krishan Kumar; Jyotirmoy Banerjee; P Sarat Chandra
Journal:  Sci Rep       Date:  2018-12-19       Impact factor: 4.379

9.  Fast Ripples as a Biomarker of Epileptogenic Tuber in Tuberous Sclerosis Complex Patients Using Stereo-Electroencephalograph.

Authors:  Yangshuo Wang; Liu Yuan; Shaohui Zhang; Shuangshuang Liang; Xiaoman Yu; Tinghong Liu; Xiaofeng Yang; Shuli Liang
Journal:  Front Hum Neurosci       Date:  2021-06-16       Impact factor: 3.169

10.  Specific pattern of maturation and differentiation in the formation of cortical tubers in tuberous sclerosis omplex (TSC): evidence from layer-specific marker expression.

Authors:  Angelika Mühlebner; Anand M Iyer; Jackelien van Scheppingen; Jasper J Anink; Floor E Jansen; Tim J Veersema; Kees P Braun; Wim G M Spliet; Wim van Hecke; Figen Söylemezoğlu; Martha Feucht; Pavel Krsek; Josef Zamecnik; Christian G Bien; Tilman Polster; Roland Coras; Ingmar Blümcke; Eleonora Aronica
Journal:  J Neurodev Disord       Date:  2016-04-01       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.